Stay updated on HER2+ Breast Cancer Adjuvant Trial

Sign up to get notified when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2+ Breast Cancer Adjuvant Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T19:20:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed descriptions of a clinical trial comparing treatments for HER2-positive breast cancer, while retaining some key identifiers such as the EudraCT number and the study's location.
    Difference
    41%
    Check dated 2025-04-16T13:24:31.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 11, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.5%
    Check dated 2025-04-09T06:56:46.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:24:37.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The study on HER2-positive early breast cancer has been updated to reflect a new patient allocation of approximately 520 instead of 700, and the hospital name has changed from Helsinki University Central Hospital to Helsinki University Hospital. Additionally, the last update date has been revised to February 2025.
    Difference
    2%
    Check dated 2025-02-17T14:36:18.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    2%
    Check dated 2025-02-10T09:37:06.000Z thumbnail image

Stay in the know with updates to HER2+ Breast Cancer Adjuvant Trial

Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.